Selected research
Market Structure
Global Nicotinamide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Nicotinamide Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Nicotinamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nicotinamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nicotinamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Nicotinamide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nicotinamide Tablets include Puritan’s Pride, Swisse, CONBA, Shanghai Pharma, Century Huaxing Biological Engineering and Tianjin Lisheng Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Nicotinamide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nicotinamide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nicotinamide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.
Nicotinamide Tablets Segment by Company
Puritan’s Pride
Swisse
CONBA
Shanghai Pharma
Century Huaxing Biological Engineering
Tianjin Lisheng Pharmaceutical
Nicotinamide Tablets Segment by Type
50mg/Tablets
100mg/Tablets
Nicotinamide Tablets Segment by Application
Online Sales
Offline Sales
Nicotinamide Tablets Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Nicotinamide Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nicotinamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nicotinamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Nicotinamide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg/Tablets
- 100mg/Tablets
Applications
- Online Sales
- Offline Sales
Companies covered
- Puritan’s Pride
- Swisse
- CONBA
- Shanghai Pharma
- Century Huaxing Biological Engineering
- Tianjin Lisheng Pharmaceutical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Nicotinamide Tablets Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Nicotinamide Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Nicotinamide Tablets Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Nicotinamide Tablets Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Nicotinamide Tablets Market Dynamics
- 2.1 Nicotinamide Tablets Industry Trends
- 2.2 Nicotinamide Tablets Industry Drivers
- 2.3 Nicotinamide Tablets Industry Opportunities and Challenges
- 2.4 Nicotinamide Tablets Industry Restraints
3 Nicotinamide Tablets Market by Manufacturers
- 3.1 Global Nicotinamide Tablets Revenue by Manufacturers (2021-2026)
- 3.2 Global Nicotinamide Tablets Sales by Manufacturers (2021-2026)
- 3.3 Global Nicotinamide Tablets Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Nicotinamide Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nicotinamide Tablets Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Nicotinamide Tablets Manufacturers, Product Type & Application
- 3.7 Global Nicotinamide Tablets Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nicotinamide Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nicotinamide Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Nicotinamide Tablets Tier 1, Tier 2, and Tier 3
4 Nicotinamide Tablets Market by Type
- 4.1 Nicotinamide Tablets Type Introduction
- 4.1.1 50mg/Tablets
- 4.1.2 100mg/Tablets
- 4.2 Global Nicotinamide Tablets Sales by Type
- 4.2.1 Global Nicotinamide Tablets Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Nicotinamide Tablets Sales by Type (2021-2032)
- 4.2.3 Global Nicotinamide Tablets Sales Market Share by Type (2021-2032)
- 4.3 Global Nicotinamide Tablets Revenue by Type
- 4.3.1 Global Nicotinamide Tablets Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Nicotinamide Tablets Revenue by Type (2021-2032)
- 4.3.3 Global Nicotinamide Tablets Revenue Market Share by Type (2021-2032)
5 Nicotinamide Tablets Market by Application
- 5.1 Nicotinamide Tablets Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Nicotinamide Tablets Sales by Application
- 5.2.1 Global Nicotinamide Tablets Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Nicotinamide Tablets Sales by Application (2021-2032)
- 5.2.3 Global Nicotinamide Tablets Sales Market Share by Application (2021-2032)
- 5.3 Global Nicotinamide Tablets Revenue by Application
- 5.3.1 Global Nicotinamide Tablets Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Nicotinamide Tablets Revenue by Application (2021-2032)
- 5.3.3 Global Nicotinamide Tablets Revenue Market Share by Application (2021-2032)
6 Global Nicotinamide Tablets Sales by Region
- 6.1 Global Nicotinamide Tablets Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Nicotinamide Tablets Sales by Region (2021-2032)
- 6.2.1 Global Nicotinamide Tablets Sales by Region (2021-2026)
- 6.2.2 Global Nicotinamide Tablets Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Nicotinamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Nicotinamide Tablets Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Nicotinamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Nicotinamide Tablets Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Nicotinamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Nicotinamide Tablets Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Nicotinamide Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Nicotinamide Tablets Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Nicotinamide Tablets Revenue by Region
- 7.1 Global Nicotinamide Tablets Revenue by Region
- 7.1.1 Global Nicotinamide Tablets Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Nicotinamide Tablets Revenue by Region (2021-2026)
- 7.1.3 Global Nicotinamide Tablets Revenue by Region (2027-2032)
- 7.1.4 Global Nicotinamide Tablets Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Nicotinamide Tablets Revenue (2021-2032)
- 7.2.2 North America Nicotinamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Nicotinamide Tablets Revenue (2021-2032)
- 7.3.2 Europe Nicotinamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Nicotinamide Tablets Revenue (2021-2032)
- 7.4.2 Asia-Pacific Nicotinamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Nicotinamide Tablets Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Nicotinamide Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Puritan’s Pride
- 8.1.1 Puritan’s Pride Company Information
- 8.1.2 Puritan’s Pride Business Overview
- 8.1.3 Puritan’s Pride Nicotinamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Puritan’s Pride Nicotinamide Tablets Product Portfolio
- 8.1.5 Puritan’s Pride Recent Developments
- 8.2 Swisse
- 8.2.1 Swisse Company Information
- 8.2.2 Swisse Business Overview
- 8.2.3 Swisse Nicotinamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Swisse Nicotinamide Tablets Product Portfolio
- 8.2.5 Swisse Recent Developments
- 8.3 CONBA
- 8.3.1 CONBA Company Information
- 8.3.2 CONBA Business Overview
- 8.3.3 CONBA Nicotinamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CONBA Nicotinamide Tablets Product Portfolio
- 8.3.5 CONBA Recent Developments
- 8.4 Shanghai Pharma
- 8.4.1 Shanghai Pharma Company Information
- 8.4.2 Shanghai Pharma Business Overview
- 8.4.3 Shanghai Pharma Nicotinamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Shanghai Pharma Nicotinamide Tablets Product Portfolio
- 8.4.5 Shanghai Pharma Recent Developments
- 8.5 Century Huaxing Biological Engineering
- 8.5.1 Century Huaxing Biological Engineering Company Information
- 8.5.2 Century Huaxing Biological Engineering Business Overview
- 8.5.3 Century Huaxing Biological Engineering Nicotinamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Century Huaxing Biological Engineering Nicotinamide Tablets Product Portfolio
- 8.5.5 Century Huaxing Biological Engineering Recent Developments
- 8.6 Tianjin Lisheng Pharmaceutical
- 8.6.1 Tianjin Lisheng Pharmaceutical Company Information
- 8.6.2 Tianjin Lisheng Pharmaceutical Business Overview
- 8.6.3 Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Tianjin Lisheng Pharmaceutical Nicotinamide Tablets Product Portfolio
- 8.6.5 Tianjin Lisheng Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Nicotinamide Tablets Value Chain Analysis
- 9.1.1 Nicotinamide Tablets Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Nicotinamide Tablets Production Mode & Process
- 9.2 Nicotinamide Tablets Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nicotinamide Tablets Distributors
- 9.2.3 Nicotinamide Tablets Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst